Eyepoint Pharmaceuticals Inc (EYPT) — Financial Flexibility Index
Eyepoint Pharmaceuticals Inc (EYPT) has a Financial Flexibility Index of -1.14x as of September 2025. Free cash flow of $-58.56 Million (operating CF $-59.35 Million minus capex $798.00K) represents -1% of total liabilities ($51.51 Million). Check Eyepoint Pharmaceuticals Inc (EYPT) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eyepoint Pharmaceuticals Inc Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Eyepoint Pharmaceuticals Inc across 23 annual periods. See EYPT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Eyepoint Pharmaceuticals Inc (2002–2024)
Year-by-year free cash flow to debt coverage for Eyepoint Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is Eyepoint Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.49x | $-122.17 Million | $-126.23 Million | $81.96 Million | ▼ -2572.1% |
| 2023 | 0.06x | $5.36 Million | $1.88 Million | $88.86 Million | ▲ +108.1% |
| 2022 | -0.75x | $-62.85 Million | $-65.00 Million | $83.99 Million | ▼ -18.4% |
| 2021 | -0.63x | $-49.94 Million | $-50.10 Million | $78.99 Million | ▼ -228.7% |
| 2020 | -0.19x | $-14.07 Million | $-14.44 Million | $73.18 Million | ▲ +78.0% |
| 2019 | -0.87x | $-56.49 Million | $-56.70 Million | $64.64 Million | ▼ -140.4% |
| 2018 | -0.36x | $-21.80 Million | $-21.91 Million | $59.98 Million | ▲ +90.5% |
| 2017 | -3.81x | $-20.34 Million | $-20.49 Million | $5.34 Million | ▼ -152.4% |
| 2016 | -1.51x | $-16.20 Million | $-16.32 Million | $10.74 Million | ▼ -229.8% |
| 2015 | 1.16x | $10.46 Million | $10.30 Million | $9.00 Million | ▲ +186.4% |
| 2014 | -1.35x | $-10.42 Million | $-10.67 Million | $7.75 Million | ▼ -32.6% |
| 2013 | -1.01x | $-8.68 Million | $-8.74 Million | $8.55 Million | ▲ +17.8% |
| 2012 | -1.23x | $-8.60 Million | $-9.00 Million | $6.96 Million | ▼ -293.6% |
| 2011 | -0.31x | $-3.04 Million | $-3.17 Million | $9.68 Million | ▼ -131.6% |
| 2010 | 0.99x | $9.91 Million | $9.90 Million | $9.97 Million | ▲ +263.6% |
| 2009 | -0.61x | $-8.24 Million | $-8.44 Million | $13.56 Million | ▼ -117.5% |
| 2008 | -0.28x | $-4.87 Million | $-5.14 Million | $17.44 Million | ▲ +73.3% |
| 2007 | -1.05x | $-21.13 Million | $-21.21 Million | $20.21 Million | ▼ -119.1% |
| 2006 | -0.48x | $-14.98 Million | $-16.14 Million | $31.40 Million | ▲ +89.0% |
| 2005 | -4.34x | $-6.75 Million | $-9.34 Million | $1.56 Million | ▲ +0.0% |
| 2004 | -4.34x | $-6.75 Million | $-9.34 Million | $1.56 Million | ▼ -15.4% |
| 2003 | -3.76x | $-5.07 Million | $-5.44 Million | $1.35 Million | ▲ +26.8% |
| 2002 | -5.14x | $-3.02 Million | $-3.06 Million | $588.38K | — |